{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:28:38Z","timestamp":1759937318643},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,15]],"date-time":"2015-07-15T00:00:00Z","timestamp":1436918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0132780","type":"journal-article","created":{"date-parts":[[2015,7,15]],"date-time":"2015-07-15T18:40:22Z","timestamp":1436985622000},"page":"e0132780","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?"],"prefix":"10.1371","volume":"10","author":[{"given":"Sabrina","family":"Pagano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert","family":"Gaertner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Cerini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiphaine","family":"Mannic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Satta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscila Camillo","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Mach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Vuilleumier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,7,15]]},"reference":[{"issue":"25","key":"ref1","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1161\/01.CIR.0000133321.00456.00","article-title":"Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association","volume":"109","author":"H Eyre","year":"2004","journal-title":"Circulation"},{"issue":"2A","key":"ref2","doi-asserted-by":"crossref","first-page":"2H","DOI":"10.1016\/j.amjcard.2006.03.002","article-title":"From vulnerable plaque to vulnerable patient\u2014Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report","volume":"98","author":"M Naghavi","year":"2006","journal-title":"Am J Cardiol"},{"issue":"7347","key":"ref3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"P Libby","year":"2011","journal-title":"Nature"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12016-010-8233-z","article-title":"Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases","volume":"44","author":"P Roux-Lombard","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1073\/pnas.0506877103","article-title":"Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases","volume":"103","author":"AA Ajees","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"31","key":"ref6","doi-asserted-by":"crossref","first-page":"22249","DOI":"10.1074\/jbc.R700014200","article-title":"The Structure of Apolipoprotein A-I in High Density Lipoproteins","volume":"282","author":"WS Davidson","year":"2007","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms","volume":"8","author":"M Navab","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"ref8","first-page":"w13781","article-title":"Pro- or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins?","volume":"143","author":"N Vuilleumier","year":"2013","journal-title":"Swiss Med Wkly"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/0961203309357765","article-title":"High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome","volume":"19","author":"PR Ames","year":"2010","journal-title":"Lupus"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1196\/annals.1422.016","article-title":"Antibodies toward high-density lipoprotein components inhibit paraoxonase activity in patients with systemic lupus erythematosus","volume":"1108","author":"JR Batuca","year":"2007","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1191\/096120398678920262","article-title":"Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE","volume":"7","author":"AR Dinu","year":"1998","journal-title":"Lupus"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1002\/art.27546","article-title":"Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis","volume":"62","author":"N Vuilleumier","year":"2010","journal-title":"Arthritis and rheumatism"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3109\/03009741003742755","article-title":"Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity","volume":"39","author":"N Vuilleumier","year":"2010","journal-title":"Scandinavian journal of rheumatology"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2796.2011.02479.x","article-title":"Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction","volume":"271","author":"PF Keller","year":"2012","journal-title":"J Intern Med"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/eurheartj\/ehq521","article-title":"Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability","volume":"32","author":"F Montecucco","year":"2011","journal-title":"European heart journal"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","DOI":"10.1160\/TH12-10-0714","article-title":"Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy","volume":"109","author":"N Vuilleumier","year":"2013","journal-title":"Thromb Haemost"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/eurheartj\/ehq055","article-title":"Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction","volume":"31","author":"N Vuilleumier","year":"2010","journal-title":"European heart journal"},{"issue":";","key":"ref18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/acr.21631","article-title":"Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?","volume":"64","author":"A Finckh","year":"2012","journal-title":"Arthritis care & research"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2796.2012.02530.x","article-title":"Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2\/CD14 complex","volume":"272","author":"S Pagano","year":"2012","journal-title":"J Intern Med"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1210\/en.2011-1835","article-title":"Antiapolipoprotein A-1 IgG chronotropic effects require nongenomic action of aldosterone on L-type calcium channels","volume":"153","author":"MF Rossier","year":"2012","journal-title":"Endocrinology"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/art.27764","article-title":"Autoimmune-mediated reduction of high-density lipoprotein-cholesterol and paraoxonase 1 activity in systemic lupus erythematosus-prone gld mice","volume":"63","author":"R Srivastava","year":"2011","journal-title":"Arthritis and rheumatism"},{"issue":"20","key":"ref22","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"K Thygesen","year":"2012","journal-title":"Eur Heart J"},{"issue":"34","key":"ref23","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/0040-4039(93)85003-F","article-title":"A novel, convenient, three-dimensional orthogonal strategy for solid phase synthesis of cyclic peptides","author":"SA Kates","year":"1993","journal-title":"Tetrahedron letters"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/bip.10203","article-title":"The synthesis and study of side-chain lactam-bridged peptides","volume":"66","author":"JW Taylor","year":"2002","journal-title":"Biopolymers"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: A method for prognostication and therapeutic decision making","volume":"284","author":"EM Antman","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"ER DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1038\/nprot.2010.146","article-title":"Solid-phase synthesis of short alpha-helices stabilized by the hydrogen bond surrogate approach","volume":"5","author":"A Patgiri","year":"2010","journal-title":"Nat Protoc"},{"issue":"41","key":"ref28","doi-asserted-by":"crossref","first-page":"28249","DOI":"10.1074\/jbc.M114.589002","article-title":"Definition of human apolipoprotein a-I epitopes recognized by autoantibodies present in patients with cardiovascular diseases","volume":"289","author":"PC Teixeira","year":"2014","journal-title":"J Biol Chem"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/BOR.0b013e32835461d3","article-title":"Streptococcus and rheumatic fever","volume":"24","author":"MW Cunningham","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood-2010-08-301424","article-title":"Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia","volume":"117","author":"K Krauel","year":"2011","journal-title":"Blood"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1473-3099(01)00019-6","article-title":"Infectious origins of, and molecular mimicry in, Guillain-Barre and Fisher syndromes","volume":"1","author":"N Yuki","year":"2001","journal-title":"The Lancet infectious diseases"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/jre.12014","article-title":"Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis","volume":"48","author":"PA Wick","year":"2013","journal-title":"J Periodontal Res"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1194\/jlr.M011098","article-title":"Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function","volume":"52","author":"CE Watson","year":"2011","journal-title":"J Lipid Res"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/MED.0000000000000049","article-title":"Treatment options for low high-density lipoproteins","volume":"21","author":"A Hafiane","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1194\/jlr.P800003-JLR200","article-title":"Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients","volume":"49","author":"LT Bloedon","year":"2008","journal-title":"J Lipid Res"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.cbpa.2008.08.019","article-title":"Contemporary strategies for the stabilization of peptides in the alpha-helical conformation","volume":"12","author":"LK Henchey","year":"2008","journal-title":"Current opinion in chemical biology"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.amjmed.2010.07.023","article-title":"Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI","volume":"124","author":"DD McManus","year":"2011","journal-title":"Am J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0132780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T09:43:00Z","timestamp":1540028580000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0132780"}},"subtitle":[],"editor":[{"given":"Carmine","family":"Pizzi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,15]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0132780","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,15]]}}}